期刊文献+

核因子-κB“诱饵性”寡核苷酸抑制LPS诱导的肠上皮细胞TLR4、IL-8的表达 被引量:5

Inhibitory effect of NF-κB decoy ODN on expressions of TLR4 and IL-8 in LPS-induced intestinal epithelial cells
下载PDF
导出
摘要 目的:研究NF-κBdecoy寡核苷酸对LPS诱导结肠癌细胞SW480后,对TLR4、IL-8表达的影响。方法:体外培养SW480细胞,用LPS(10μg/L)刺激3h后,用脂质体lipofectin2000介导NF-κBdecoyODNs转染6h,收集细胞上清液,用ELISA法检测IL-8;提取细胞mRNA,经RT-PCR法检测TLR4 mRNA、IL-8 mRNA的表达。并设对照组、ScrambledODNs组、lipofectin2000组进行比较。结果:LPS刺激后TLR4 mRNA、IL-8 mRNA和IL-8的表达明显强于对照组;用NF-κBdecoy寡核苷酸干预,可以明显抑制TLR4 mRNA、IL-8 mRNA和IL-8的表达。而ScrambledODNs组和转染剂lipofectin2000组对其没有明显影响。结论:NF-κBdecoyODNs有望成为治疗IBD的一种新型基因药品。 AIM: To study the effect of NF - κB decoy oligodeoxynucleotides (ODNs) on TLR4 and IL -8 expression in LPS - induced SW480 cells. METHODS: SW480 cells were cultured in vitro and stimulated for 3 h with LPS (10 μg/L). NF- κB decoy oligodeoxynucleotides mediated by lipofectin 2000 were added into the cell culture for 6 h. The supernatants were collected and messured for IL -8 by ELISA. TLR4 mRNA and IL- 8 mRNA were examined by RT -PCR, respectively. The results were compared with control group, Scrambled ODNs group and lipofectin 2000 group. RESULTS: After SW480 cells were stimulated by LPS, TLR4 mRNA, IL- 8 mRNA and IL- 8 expressions were signifi- candy increased, and the difference compared with control group was obvious. After treated with NF - κB decoy oligodeoxy- nucleotides, TLR4 mRNA, IL- 8 mRNA and IL- 8 expressions were significantly inhibited. The Scrambled ODNs group and lipofectin 2000 group had no effect on them. CONCLUSION: NF - κB decoy ODNs will become a new gene drug for treating inflammatory bowel disease(IBD).
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2007年第5期934-938,共5页 Chinese Journal of Pathophysiology
基金 河北医科大学第二医院科研基金资助项目(No.2h1200606)
关键词 NF—κ寡核苷酸类 脂多糖类 SW480细胞 受体 Toll样 NF - kappa B Oligonucleotides Lipopolysaccharides SW480 cells Receptors, Toll - like
  • 相关文献

参考文献2

二级参考文献17

  • 1安静,黎鳌,杨宗城.胎儿脐静脉内皮细胞的培养[J].第三军医大学学报,1990,12(3):222-224. 被引量:51
  • 2Chen FE, Huang DB, Chen YQ, et al. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature,1998,391:410-413.
  • 3Zingarelli B, Sheehan M, Wong HR. Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med, 2003, 31 Suppl 1: S105-S111.
  • 4Bielinska A, Shivdasani RA, Zhang LQ, et al. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science,1990,16: 997-1000.
  • 5Morishita R, Gary H, Masatsugu H, et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA,1995, 92: 5855-5859.
  • 6Hosoya T;Takeuchi H;Kanesaka Y.Sequence-specific inhibition of a transcription factor by circular dumbbell DNA oligonucleotides[J],1999(3).
  • 7Marumo T;Schini-Kerth VB;Busse R.Vascular endothelial growth factor activates nuclear factor-kappa B and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells[J],1999(5).
  • 8Koch T.Origin and mediators involved in sepsis and the systemic inflammatory response syndrome,1998(53).
  • 9GoebelerM;Gillitzer R;Kilian K.Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells[J],2001.
  • 10Yamamoto Y;Gaynor RB.Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer[J],2001.

共引文献8

同被引文献74

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部